Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110467585A introduces a mild visible light method for benzothiazole derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced ruthenium complex photosensitizer patent CN107602619A offers low-cost visible light absorption for scalable photocatalytic systems and enzyme conjugation.
Patent CN110590774B discloses a green photocatalytic method for C3-trifluoromethylation of imidazo-fused rings, offering mild conditions and high purity for pharmaceutical intermediates.
Patent CN110590774B details a green photocatalytic route for C3-trifluoromethylation, offering mild conditions and high purity for pharmaceutical intermediates.
Patent CN108456227B reveals efficient photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high regioselectivity.
Patent CN110028403A reveals visible light dicarboxylation. Offers mild conditions and scalable succinic acid manufacturing for pharma intermediates.
Patent CN115368238A reveals a catalyst-free visible light method for trans-olefins. Achieves >100:1 stereoselectivity at room temperature, offering significant cost reduction.
Patent CN111333558A details a catalyst-free visible light method for α-selenyl ketones. Discover cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Novel visible-light method for high-purity pharmaceutical intermediates. Reduces cost and environmental impact significantly for global supply chains.
Patent CN113845427B reveals a green visible light method for aryl compounds. This report analyzes cost reduction and supply chain reliability for fine chemical intermediates manufacturing.
Patent CN109293541A enables room temperature synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
This report analyzes patent CN115043810B detailing non-metal catalyzed oxidation. It offers supply chain leaders cost reduction strategies and high-purity pharmaceutical intermediate manufacturing insights for global procurement.
Patent CN110551059B reveals a metal-free, visible-light driven synthesis of 3-sulfonylspiro[4,5]trienones using DABSO, offering significant cost reduction and supply chain stability.
Patent CN115057840B details a visible light-promoted synthesis of 3-acyl coumarins. This method offers cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN107445795A reveals a visible-light photocatalytic method for fluorinated aryl blocks. Enables cost reduction in agrochemical manufacturing and high-purity supply.
Patent CN116159594A introduces a metal-free photocatalytic route for quinazolinones. This green method offers significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN118084596B enables visible light catalytic hydrogenation of aromatic olefins. Achieve high-purity intermediates with reduced costs and mild reaction conditions for scalable manufacturing.
Novel visible-light synthesis of fluoroalkyl indolines using Eosin Y. Green chemistry, mild conditions, high yield for pharmaceutical intermediates.
Patent CN112442002A details a metal-free photocatalytic route for 11-sulfenyl naphtho[2,3-b]benzofuran. Discover cost-effective manufacturing and supply chain advantages.
Patent CN121517276A reveals metal-free photocatalytic synthesis for polyfluoroalkyl aromatic hydrocarbons offering cost reduction and supply chain reliability for fine chemical intermediates manufacturing.